How Sunstone Therapies is Opening Doors to Psychedelic Treatment
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
How Sunstone Therapies is Opening Doors to Psychedelic Treatment
-
Narrated by:
-
By:
About this listen
In this episode I speak to Norma Stevens, LCPC, the Director of Therapy Operations at Sunstone Therapies in Rockville, Maryland. Sunstone partners with companies like Beckley PsyTech, COMPASS Pathways, MindMed, MAPS (Lykos Theraputics), Reunion Neuroscience, and Usona to run studies that aim to establish the gold standard for psychedelic treatments of complex mental health challenges.
Sunstone offers research trials in a unique partnership with the Acquilino Cancer Center, a research program within Adventist HealthCare. Sunstone works with psilocybin, MDMA, 5-MeO-DMT, and LSD in conjunction with psychotherapy. We discuss the role of psychological integration after a psychedelic journey and the importance of a therapeutic set and setting.
No reviews yet